TP53 and cancer: Simbolo and colleagues found that individuals with atypical lung carcinoids and large cell neuroendocrine carcinomas of the lung who had inactivating mutations in p53 and Rb but intact menin expression had shorter cancer-specific survival than individuals with inactivating p53 and menin mutations or intermediate features [109].